пятница, 26 февраля 2016 г.

The Verdict Against Johnson & Johnson Doesn't Mean More Judgements Will Follow

The Verdict Against Johnson & Johnson Doesn't Mean More Judgements Will Follow


The $72 million verdict this week against Johnson & Johnson in a U.S. case alleging links between talc-based powder and ovarian cancer has prompted global headlines, social-media buzz and calls to lawyers from would-be plaintiffs. But the attention-grabbing judgment is no guarantee future plaintiffs will be able to convince juries the company's products caused their illnesses.



from Biotech News